Bold Therapeutics to Initiate Phase 1b Trial of BOLD-100 in GI Cancers

Mark Bazett 02-10-2020

Bold Therapeutics Visiting Collaborators in Europe

Bold Therapeutics will be visiting with multiple collaborators, vendors and partners in Europe from March 2nd to 6th.